The activation of NFκB and the acute activation of TGF-β1 in human dystrophin-deficient muscle cause metabolic pathway failure later in the disease and appear to be associated with symptoms and muscle wasting in DMD [21]. The gene discussed is TGFB1; the disease is Duchenne muscular dystrophy.